Lack of effect of repeated administration of milnacipran, a double noradrenaline and serotonin reuptake inhibitor, on the β-adrenoceptor-linked adenylate cyclase system in the rat cerebral cortex

Neuropharmacology

Volumn 35, Issue 5, 1996, Pages 589-593

  Neliat, G ^a   Bodinier, M C ^a   Panconi, E ^b   Briley, M ^b  

^a CEREP   (France)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Adenylate cyclase; Antidepressants; imipramine; Milnacipran; adrenoceptor binding; adrenoceptor linked adenylate cyclase

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; FORSKOLIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); IMIPRAMINE; ISOPRENALINE; MILNACIPRAN; RADIOLIGAND; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DISSOCIATION CONSTANT; ENZYME ACTIVITY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

EID: 0030152010     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-3908(96)84628-4     Document Type: Article

References (25)

1. Ansseau M., Von Frenckell R., Mertens C., De Wilde J., Botte L., Devoitille J.M., Evrard J.L., De Nayer A., Darimont P., Dejaiffe G., Mirel J., Meurice E., Parent M., Couzinier J.P., Demarez J.P., Serre C. Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients. Psychopharmacology. 98:1989;163-168.
2. Assié M.B., Le Lann A.-D., Stenger A., Briley M. Repeated administration of milnacipran, a new antidepressant, has no effect on a functional β-adrenergic response in the rat brain. Eur. J. Pharmacol. 183:1990;741-742.
3. Assié M.B., Charvéron M., Palmier C., Puozzo C., Moret C., Briley M. Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat. Neuropharmacology. 31:1992;149-155.
4. Barbaccia M.L., Ravizza L., Costa E. Maprotiline: an antidepressant with an unusual pharmacological profile. J. Pharmacol. Exp. Ther. 236:1986;307-312.
5. Benfield P., Ward A. Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drug. 32:1986;313-334.
6. Bergstrom D.A., Kellar K.J. Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment. J. Pharmacol. Exp. Ther. 209:1979;256-261.
7. Carré J.B., Boutry J.M., Baumann N., Maurin Y. Acidic sphingomyelinase: relationship with antidepressant-induced desensitisation of β-adrenoceptors. Life Sci. 42:1988;769-774.
8. Duncan G.E., Knapp D.J., Little K.Y., Breese G.R. Neuroanatomical specificity and dose dependence in the time course of imipramine-induced beta adrenergic receptor down-regulation in rat brain. J. Pharmacol. Exp. Ther. 271:1994;1699-1704.
9. 2-adrenergic, imipramine or dopaminergic receptors in the brain. Neuropharmacology. 22:1983;1257-1267.
10. Gandolfi O., Barbaccia M.L., Chuang M.D., Costa E. Daily bupropion injections for three weeks attenuate the NE-stimulation of adenylate cyclase and the number of β-adrenergic recognition sites in rat frontal cortex. Neuropharmacology. 22:1983;927-929.
11. Hyttel J., Overo F.K., Arnt J. Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram. Psychopharmacology. 83:1984;20-27.
12. Matsubara R., Koyama T., Odagaki Y., Nakayama M., Inoue T., Yamashita I. Pharmacological properties of midalcipran (F 2207), a novel antidepressant. Psychopharmacology. 96:1988;S273.
13. Matsubara R., Koyama T. Muraki A., Matsubara S., Odagaki Y., Nakayama M., Yamashita I. (1990) Effect of Chronic Treatment with Milnacipran (F 2207) on β-adrenergic Receptor-adenylate Cyclase System in Rat Cerebral Cortex. Abstract, 17th CINP meeting, Kyoto, p. 70.
14. Moret C., Charvéron M., Finberg J.P.M., Couzinier J.P., Briley M. Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug. Neuropharmacology. 24:1985;1211-1219.
15. Moret C. and Briley M. (1996) In Vivo Studies of Monoamine Neurotransmission by Milnacipran, a Double Noradrenaline and Serotonin Reuptake Inhibiting Antidepressant. Abstract Brain Research Association meeting Newcastle, U.K., p. 35.
16. Mork A., Geisler A. Effects of GTP on hormone-stimulated adenylate cyclase activity in cerebral cortex, striatum, and hippocampus from rats treated chronically with lithium. Biol. Psychiat. 26:1989;279-288.
17. Nelson D.R., Thomas D.R., Johnson A.M. Pharmacological effects of paroxetine after repeated administration to animals. Acta Psychiatr. Scand. 350((suppl)):1989;21-23.
18. Olpe H.-R., Schellenberg A. Reduced sensitivity of neurons to noradrenaline after chronic treatment with antidepressant drugs. Eur. J. Pharmacol. 63:1980;7-13.
19. Redmond A.M., Kelly J.P., Leonard B.E. The behavioural effects of milnacipran in the olfactory bulbectomised rat model of depression. Med. Sci. Res. 23:1995;533-534.
20. Riva M.A., Creese I. Reevaluation of the regulation of β-adrenergic receptor binding by desipramine treatment. Molec. Pharmacol. 36:1989;211-218.
21. Sarai K., Frazer A., Brunswick D., Mendels J. Desmethylimipramine-induced decrease in β-adrenergic receptor binding in rat cerebral cortex. Biochem. Pharmacol. 27:1978;2179-2181.
22. Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Analyt. Biochem. 58:1974;541-548.
23. 2 and postsynaptic beta-adrenoceptor sensitivity in slices of rat neocortex after chronic treatment with various antidepressant drugs. Neuropharmacology. 23:1984;115-119.
24. Stenger A., Couzinier J.P., Briley M. Psychopharmacology of midalcipran, 1-phenyl-1-diethyl-aminocarbonyl-2-amino-methyl-cyclopropane hydrochloride (F 2207), a new potential antidepressant. Psychopharmacology. 91:1987;147-153.
25. Sulser F., Janowsky A.J., Okada F., Manier D.H., Mobley P.L. Regulation of recognition and action function of the norepinephrine (NE) receptor-coupled adenylate cyclase system in the brain. Implications for the therapy of depression. Neuropharmacology. 22:1983;425-431.